Christopher Brueckner

Statistics

Publications

Citations

249

H-Index

Active since

2020

Affiliations

Scholar Rock (United States)(Current)

Christopher Brueckner is an author at Scholar Rock (United States) specializing in resistance to checkpoint inhibitors, molecular oncology, and tumor immunology.

ORCID

Publications per year

2020–2024

Publications

Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape

Constance J. Martin, Abhishek Datta, Christopher Littlefield et al. · Science Translational Medicine · 2020 · 231 citations

Medicine, Immunology, Oncology +14

An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis

Justin Jackson, Frederick C. Streich, Ajai Pal et al. · Science Signaling · 2024 · 18 citations

Life Sciences, Immunology, Molecular Biology +17

1–2 of 2